Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blueberries MedicalBBRRF -3.62% 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. The stock has 2 warning signs investors should review. Among 513 Drug Manufacturers companies, Blueberries Medical ranks worse than 194931.58% on this metric.
Blueberries Medical's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Blueberries Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
BBRRF's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.29 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Blueberries Medical (OTCPK:BBRRF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Blueberries Medical 5-Year Yield-on-Cost % Related Terms
BBRRF vs ZTS, UTHR: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's 5-Year Yield-on-Cost % falls into.
Blueberries Medical 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Blueberries Medical (BBRRF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 22, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Blueberries Medical and its competitors. According to the industry distribution chart, Blueberries Medical ranks #999999 out of 513 companies in the Drug Manufacturers industry.
Is Blueberries Medical's 5-Year Yield-on-Cost % too high?
Blueberries Medical's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Blueberries Medical ranks #999999 out of 513 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Blueberries Medical's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #999999 out of 513 companies for 5-Year Yield-on-Cost %. This places Blueberries Medical in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.29, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 
